The study data were collected using a demographic form. Also, the Mini-Mental State Examination (MMSE) questionnaire was used for measuring the cognitive status of the subjects. MMSE is a 30-item tool that screens and assesses the severity of cognitive impairment in terms of awareness of time and place, registration, attention, calculation, recall, language, executive skills, reading, writing, and drawing [6] . AA100 AutoAnalyzer was used for measuring subjects' serum lipids and blood glucose levels and the Friedewald formula was employed for calculating low-density lipoprotein level [7, 8] .
The obtained data were analyzed in SPSS V. 22 by using descriptive statistics (frequency, percentage, mean, standard deviation) and inferential statistics (Kolmogorov-Smirnov, Chi-squared, and 1-way ANOVA). For evaluating study hypotheses and research questions, the Tukey post hoc test was used. The significance level was set at less than 0.05 (P<0.05).
Results
Most study participants were male (55.4%) with a Mean±SD age of 69.40±7.40 years. The Mean±SD MMSE score of the subjects was 25.3±3.93. According to the results, 30 .6% of the subjects (n=465) had abnormal cognition (mild, moderate, and severe cognitive impairment) and in particular 13 (9%) had severe cognitive impairment. Based on the Chi-squared test results, there was a significant relationship between gender and cognitive impairment (P<0.05), but other underlying factors, including smoking, history of stroke, heart attacks, epilepsy and seizure, heart failure, diabetes, and hypertension had no significant association with cognitive impairment (P>0.05).
One-way ANOVA was used to compare the mean values of studied variables (age, blood pressure, blood sugar, cholesterol, triglycerides, and lipoprotein) between groups with different levels of cognitive impairments; the results are presented in Table 1 . As seen, there is a significant difference between variables of age, systolic blood pressure, total cholesterol level, and low-density lipoprotein among subjects with different levels of cognitive impairment (P<0.05). The Tukey post hoc test results showed that variables of age (78.15±8.11 years), systolic blood pressure (148.62±24.24 mm Hg), total cholesterol level (207.46±48.05 mg/mL), and low-density lipoprotein (130.68±38.11 mg/mL) of elderlies with severe cognitive impairment (group 4) are significantly higher than those in the groups with normal, mild, and moderate cognitive impairments (groups 1 to 3).
Conclusion
Based on the study results, cognitive impairment in the elderly living in the study area is high. A significant relationship was found between cognitive impairment and old age, systolic blood pressure, total cholesterol level, and low-density lipoprotein, where the values of these factors in elderlies with severe cognitive impairment were higher than those values in groups with normal, mild, and moderate cognitive impairments. Considering the relatively high prevalence of cognitive impairment in this study, screening for cognitive impairments is one of the recommendations of this study because early diagnosis and treatment of this disease, especially in high-risk groups such as women and the elderly with hypertension and impaired serum lipid profiles, can play an important role in better controlling the disease and reducing the care burden of these patients. Moreover, due to the close relationship between depression and cognitive impairment, screening older people for depression can also be of great importance.
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